Galecto, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AADI
Aadi Bioscience, Inc. |
$3.41 | $42.72 M | -0.68 | 53 | $24.35 M |
ABOS
Acumen Pharmaceuticals, Inc. |
$1.85 | $157.41 M | -2.5 | 51 | $0 |
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$6.79 | $223.86 M | -2.51 | 58 | $0 |
ALGS
Aligos Therapeutics, Inc. |
$45.62 | $40.52 M | -0.51 | 68 | $3.95 M |
AMLX
Amylyx Pharmaceuticals, Inc. |
$3.92 | $120.37 M | -1.65 | 384 | $87.37 M |
BOLT
Bolt Biotherapeutics, Inc. |
$0.62 | $29.02 M | -0.46 | 100 | $7.88 M |
CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
CHRS
Coherus BioSciences, Inc. |
$1.62 | $193.89 M | -2.28 | 235 | $266.96 M |
CNTA
Centessa Pharmaceuticals plc |
$16.74 | $884.24 M | -6.2 | 75 | $6.85 M |
CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
LYEL
Lyell Immunopharma, Inc. |
$0.68 | $619.50 M | -2.7 | 224 | $61,000 |
MLTX
MoonLake Immunotherapeutics |
$51.75 | $2.62 B | -57.88 | 100 | $0 |
MOLN
Molecular Partners AG |
$5.06 | $135.05 M | -2.03 | 158 | $4.97 M |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
SPRO
Spero Therapeutics, Inc. |
$1.08 | $75.85 M | 3.19 | 46 | $96.74 M |
TERN
Terns Pharmaceuticals, Inc. |
$5.71 | $462.44 M | -5.67 | 66 | $0 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
